YOU ARE HERE: LAT HomeCollectionsErectile Dysfunction

Erectile Dysfunction

October 14, 2009 | Shari Roan
Men who need prostate-cancer surgery are increasingly choosing minimally invasive techniques because such surgeries typically lead to shorter hospital stays and a reduced risk of some types of complications. But a new study suggests that the risk of the most serious complications may be higher with the new technology. Minimally invasive forms of radical prostatectomy (in which the prostate gland is removed), often including the use of a robot, are heavily advertised. Procedures relying on robotic surgery have increased from 1% to 40% of all radical prostatectomies from 2001 to 2006 and may be as high as 75% of all prostate cancer surgeries today.
When 43-year-old porn actor Tyce Bune goes to work these days, he makes sure to pack something extra in his briefcase along with the usual script and change of clothes: a vial of Viagra tablets. On a typical day, when filming can stretch on for 14 hours, Bune will strip down and have sex in front of a camera crew as many as three times. During busy times, he might work five days a week.
July 6, 2008 | Janet Cromley
Lonely hearts may have one more thing to worry about -- erectile dysfunction. Crunching data from a five-year study of 959 men ages 55 to 75, Finnish researchers found that men with no signs of erectile dysfunction, who had sex once a week or more, were less likely to later develop erectile dysfunction than men who had sex less often. In fact, men who reported having intercourse fewer than once a week at the beginning of the study had twice the incidence of ED than those who had sex more often.
June 5, 2000
People in need of authoritative medical information on sexual health now have two new Web sites to contact. The American Foundation for Urologic Disease, a nonprofit organization, launched a Web site ( last month. The site was created and is maintained by medical experts. It includes a chat area monitored by a physician, information about various treatments and a confidential registry for patients to receive regular updates on medical options.
February 11, 2005 | From Associated Press
Pfizer Inc. and Microsoft Corp. are teaming up to fight the slew of spam e-mails hawking Viagra that invade consumers' computers. The companies said they had filed a total of 17 lawsuits against defendants involved in the sale and distribution of the erectile dysfunction drug. The Redmond, Wash., software giant has targeted spammers before, but this is the first time the company has joined forces with a non-technology firm.
December 29, 2006 | From Bloomberg News
Pfizer Inc. won a trademark case blocking drug makers in China from copying its Viagra erectile dysfunction pills' blue diamond shape. A Beijing court ordered the three companies to pay a $38,000 fine to Pfizer, stop producing the blue, diamond-shaped pills -- which didn't contain the active ingredient in Viagra -- and print an apology in a Chinese legal newspaper, Pfizer said.
September 30, 2008 | From Times Wire Services
Watson Pharmaceuticals Inc.'s experimental drug for prostate enlargement reduced symptoms without significant blood pressure or heart side effects, the company said. Silodosin, which Corona-based Watson intends to sell as Rapaflo, had "minimal effects" on blood pressure and heart rate during yearlong tests in people who took it alone or in combination with drugs to treat erectile dysfunction, the company said.
February 9, 2009 | By Regina Nuzzo
From a purely biomechanical point of view, the design of the human penis has its pros and cons. Thanks to clever hydraulics and some very stretchy material, the organ is capable of eyebrow-raising changes in size and shape. But indestructible it is not. "It's too bad men aren't issued an owner's manual for their penis. They don't realize it's possible to injure it during sex," says Dr. Drogo Montague, director of the center for genitourinary reconstruction at the Cleveland Clinic in Ohio.
September 27, 2010 | By P.J. Huffstutter and Andrew Zajac, Los Angeles Times
The Federal Trade Commission has filed a complaint against Los Angeles-based pomegranate juice maker Pom Wonderful and its billionaire owners, Lynda and Stewart Resnick, alleging that they violated federal law by making "false and unsubstantiated claims" about the health benefits of their products. Since its launch in 2002, the garnet-red juice in the curvy little bottle gave way to a marketing craze of flavored fruit teas, martinis and salad dressings — a culinary boom bolstered by Pom's products advertised as helping to treat conditions including heart disease, prostate cancer and erectile dysfunction.
Los Angeles Times Articles